Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals
In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against the Delta variant. In a pre-print paper that is yet to be peer-reviewed, the company claimed that the vaccine is also 63 per cent effective …
Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals Read More »
